Hasil Pencarian - Rupert Bartsch

  • Menampilkan 1 - 15 hasil dari 15
Perbaiki Hasil
  1. 1
    Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion

    Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion oleh Guenther G. Steger, Rupert Bartsch

    Diterbitkan 2011-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Indocyanine green video angiography predicts outcome of extravasation injuries.

    Indocyanine green video angiography predicts outcome of extravasation injuries. oleh Werner Haslik, Ursula Pluschnig, Günther G Steger, Christoph C Zielinski, K F Schrögendorfer, Jakob Nedomansky, Rupert Bartsch, Robert M Mader

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study

    The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study oleh Hanna L. Obermeier, Julia Riedl, Cihan Ay, Silvia Koder, Peter Quehenberger, Rupert Bartsch, Alexandra Kaider, Christoph C. Zielinski, Ingrid Pabinger

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria

    Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria oleh Christine Deutschmann, Rupert Bartsch, Christian F Singer, Daphne Gschwantler-Kaulich, Michael Seifert, Carmen Leser, Maximilian Marhold, Zsuzsanna Bago-Horvath, Georg Pfeiler

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer

    Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer oleh Maximilian Marhold, Simon Udovica, Anna Halstead, Mona Hirdler, Muna Ferner, Kerstin Wimmer, Zsuzsanna Bago-Horvath, Ruth Exner, Florian Fitzal, Kathrin Strasser-Weippl, Tim Robinson, Rupert Bartsch

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Prevalence and biopsychosocial indicators of fatigue in cancer patients

    Prevalence and biopsychosocial indicators of fatigue in cancer patients oleh Elisabeth L. Zeilinger, Irina Zrnic‐Novakovic, Claudia Oppenauer, Matthäus Fellinger, Matthias Knefel, Matthias Unseld, Theresa Wagner, Simone Lubowitzki, Rupert Bartsch, Sabine Zöchbauer‐Müller, Markus Raderer, Philipp B. Staber, Peter Valent, Alexander Gaiger

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial)

    Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial) oleh Gabriel Rinnerthaler, Simon Peter Gampenrieder, Andreas Petzer, Sonja Burgstaller, David Fuchs, Dieter Rossmann, Marija Balic, Daniel Egle, Holger Rumpold, Christian F. Singer, Rupert Bartsch, Edgar Petru, Thomas Melchardt, Hanno Ulmer, Brigitte Mlineritsch, Richard Greil

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

    Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients oleh Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler, Florian Fitzal

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab

    Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab oleh Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer, Gerwin Heller, Barbara Kiesel, Kristina Tendl-Schulz, Zsuzsanna Bago-Horvath, Julia Furtner, Johannes Leitner, Ruth Exner, Florian Fitzal, Karin Dieckmann, Georg Widhalm, Matthias Preusser, Anna Sophie Berghoff, Rupert Bartsch

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT

    Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Prim... oleh Guenther G. Steger, Daniel Egle, Rupert Bartsch, Georg Pfeiler, Edgar Petru, Richard Greil, Ruth Helfgott, Christian Marth, Leopold Öhler, Michael Hubalek, Alois Lang, Christoph Tinchon, Ferdinand Haslbauer, Andreas Redl, Karin Hock, Mathias Hennebelle, Bernhard Mraz, Michael Gnant

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field

    Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field oleh Matthias Preusser, Aysegül Ilhan-Mutlu, Gerald Prager, Thorsten Fuereder, Christine Marosi, Markus Raderer, Barbara Kiesewetter, Anna S Berghoff, Manuela Schmidinger, Maximilian Marhold, Rupert Bartsch, Thais Topakian, Hermine Agis, Thomas Brodowicz, Michael Krainer, Gottfried J Locker, Christiane Thallinger, Sabine Zöchbauer-Müller, Wolfgang Lamm

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine

    Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine oleh Viktoria Knöbl, Lukas Maier, Stefan Grasl, Carmen Kratzer, Felix Winkler, Vanessa Eder, Hubert Hayden, Maria Amparo Sahagun Cortez, Monika Sachet, Rudolf Oehler, Sophie Frantal, Christian Fesl, Karin Zehetner, Georg Pfeiler, Rupert Bartsch, Florian Fitzal, Christian F. Singer, Martin Filipits, Michael Gnant, Christine Brostjan

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

    Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology oleh Concetta Elisa Onesti, Marco Tagliamento, Giuseppe Curigliano, Nadia Harbeck, Rupert Bartsch, Hans Wildiers, Vivianne Tjan-Heijnen, Miguel Martin, Sylvie Rottey, Daniele Generali, Mario Campone, Massimo Cristofanilli, Lajos Pusztai, Marc Peeters, Guy Berchem, Javier Cortes, Thomas Ruhstaller, Eva Ciruelos, Hope S. Rugo, Guy Jerusalem

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies

    The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies oleh Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, Elisabeth L. Zeilinger, Andras Acel, Olivera Cenic, Andrea Schrott, Matthias Unseld, Anahita Paula Rassoulian, Cathrin Skrabs, Peter Valent, Heinz Gisslinger, Christine Marosi, Matthias Preusser, Gerald Prager, Gabriela Kornek, Robert Pirker, Günther G. Steger, Rupert Bartsch, Markus Raderer, Ingrid Simonitsch‐Klupp, Renate Thalhammer, Christoph Zielinski, Ulrich Jäger

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Oncological care organisation during COVID-19 outbreak

    Oncological care organisation during COVID-19 outbreak oleh Ahmad Awada, Jean-Pascal Machiels, Sylvie Rottey, Sabino De Placido, Massimo Cristofanilli, Javier Cortes, Miguel Martin, Marco Tagliamento, Marc Peeters, Mario Campone, Concetta Elisa Onesti, Hope S Rugo, Daniele Generali, Khalil Zaman, Hans Wildiers, Nadia Harbeck, Vivianne Tjan-Heijnen, Sara A Hurvitz, Guy Berchem, Rupert Bartsch, Fabio Puglisi, Volkmar Müller, Thomas Ruhstaller, PierFranco Conte

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: